Pearson Amy C S, Subramanian Arun, Schroeder Darrell R, Findlay James Y
Department of Anesthesia, Carver College of Medicine, University of Iowa, Iowa City, IA.
Department of Anesthesiology and Perioperative Medicine, Mayo College of Medicine, Rochester, MN.
Transplant Direct. 2017 Oct 6;3(11):e221. doi: 10.1097/TXD.0000000000000739. eCollection 2017 Nov.
The surgical Apgar score (SAS) is a 10-point scale using the lowest heart rate, lowest mean arterial pressure, and estimated blood loss (EBL) during surgery to predict postoperative outcomes. The SAS has not yet been validated in liver transplantation patients, because typical blood loss usually exceeds the highest EBL category. Our primary aim was to develop a modified SAS for liver transplant (SAS-LT) by replacing the EBL parameter with volume of red cells transfused. We hypothesized that the SAS-LT would predict death or severe complication within 30 days of transplant with similar accuracy to current scoring systems.
A retrospective cohort of consecutive liver transplantations from July 2007 to November 2013 was used to develop the SAS-LT. The predictive ability of SAS-LT for early postoperative outcomes was compared with Model for End-stage Liver Disease, Sequential Organ Failure Assessment, and Acute Physiology and Chronic Health Evaluation III scores using multivariable logistic regression and receiver operating characteristic analysis.
Of 628 transplants, death or serious perioperative morbidity occurred in 105 (16.7%). The SAS-LT (receiver operating characteristic area under the curve [AUC], 0.57) had similar predictive ability to Acute Physiology and Chronic Health Evaluation III, model for end-stage liver disease, and Sequential Organ Failure Assessment scores (0.57, 0.56, and 0.61, respectively).Seventy-nine (12.6%) patients were discharged from the ICU in 24 hours or less. These patients' SAS-LT scores were significantly higher than those with a longer stay (7.0 vs 6.2, < 0.01). The AUC on multivariable modeling remained predictive of early ICU discharge (AUC, 0.67).
The SAS-LT utilized simple intraoperative metrics to predict early morbidity and mortality after liver transplant with similar accuracy to other scoring systems at an earlier postoperative time point.
手术阿普加评分(SAS)是一种10分制评分,使用手术期间的最低心率、最低平均动脉压和估计失血量(EBL)来预测术后结果。SAS尚未在肝移植患者中得到验证,因为典型的失血量通常超过EBL的最高类别。我们的主要目的是通过用输注红细胞量替代EBL参数来开发一种改良的肝移植SAS(SAS-LT)。我们假设SAS-LT能够以与当前评分系统相似的准确性预测移植后30天内的死亡或严重并发症。
使用2007年7月至2013年11月连续肝移植的回顾性队列来开发SAS-LT。使用多变量逻辑回归和受试者工作特征分析,将SAS-LT对术后早期结果的预测能力与终末期肝病模型、序贯器官衰竭评估和急性生理与慢性健康状况评估III评分进行比较。
在628例移植中,105例(16.7%)发生了死亡或严重围手术期并发症。SAS-LT(曲线下受试者工作特征面积[AUC],0.57)与急性生理与慢性健康状况评估III、终末期肝病模型和序贯器官衰竭评估评分(分别为0.57、0.56和0.61)具有相似的预测能力。79例(12.6%)患者在24小时或更短时间内从重症监护病房出院。这些患者的SAS-LT评分显著高于住院时间较长的患者(7.0对6.2,<0.01)。多变量建模的AUC仍然可以预测早期重症监护病房出院(AUC,0.67)。
SAS-LT利用简单的术中指标来预测肝移植术后早期的发病率和死亡率,在术后更早的时间点,其准确性与其他评分系统相似。